Saturday, October 16, 2021
اُردُو نیوز Newspaper Live-TV(UK) Live-TV(PK)
اُردُو نیوز Newspaper
Live-TV(UK) Live-TV(PK)

FDA declines approval of AstraZeneca diabetes drug combination

FDA declines approval of AstraZeneca diabetes drug combination
October 16, 2015
LONDON - US health regulators declined to approve AstraZeneca's fixed-dose combination of the diabetes drugs saxagliptin and dapagliflozin, dealing a blow to an important plank of the drugmaker's business. AstraZeneca said on Friday it had received a so-called complete response letter from the Food and Drug Administration stating that more clinical data were required. Such letters typically outline concerns and conditions that must be addressed in order to gain U.S. approval. -Reuters
تازہ ترین خبریں حاصل کرنے کے لیے فوری اطلاع کی اجازت دیں

آپ کسی بھی وقت دائیں طرف نیچے بیل آئیکن پر صرف ایک کلک کے ذریعے آسانی سے سبسکرائب کر سکتے ہیں۔